2-morpholino-4-pyrimidone compound

Details for Australian Patent Application No. 2005280885 (hide)

Owner Sanofi-Aventis Mitsubishi Tanabe Pharma Corporation

Inventors Fukunaga, Kenji; Kohara, Toshiyuki; Uehara, Fumiaki; Yokoshima, Satoshi; Watanabe, Kazutoshi; Hiki, Shinsuke

Agent Collison & Co

Pub. Number AU-B-2005280885

PCT Pub. Number WO2006/028290

Priority 2004-296926 09.09.04 JP

Filing date 9 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 22 September 2011

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5377 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/028290 Priority application(s): WO2006/028290

2 October 2008 Alteration of Name

  The name of the applicant has been altered to Sanofi-Aventis; Mitsubishi Tanabe Pharma Corporation

22 September 2011 Application Accepted

  Published as AU-B-2005280885

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280896-Vaccine for oral administration

2005280855-Boiler furnace which avoid thermal NOx